v3.25.2
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
MiX Combination
FC Acquisition
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Common Stock
MiX Combination
Common Stock
FC Acquisition
Additional Paid-In Capital
Additional Paid-In Capital
MiX Combination
Additional Paid-In Capital
FC Acquisition
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Non-Controlling Interest
Beginning balance at Dec. 31, 2021 $ 83,351       $ 373     $ 224,852     $ (134,052)   $ 391 $ (8,299) $ 86
Beginning balance (in shares) at Dec. 31, 2021         37,263                    
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to common stockholders (16,891)             (10,137)     (6,754)        
Net income (loss) attributable to noncontrolling interest 2                           2
Foreign currency translation adjustment (1,611)                       (1,601)   (10)
Issuance of restricted shares 0       $ 5     (5)              
Issuance of restricted shares (in shares)         492                    
Forfeiture of restricted shares 0       $ (2)     2              
Forfeiture of restricted shares (in shares)         (186)                    
Vesting of restricted stock units (in shares)         36                    
Shares withheld pursuant to vesting of restricted stock (211)                         (211)  
Stock-based compensation 4,343             4,343              
Ending balance (in shares) at Dec. 31, 2022         37,605                    
Ending balance at Dec. 31, 2022 $ 68,983     $ 200 $ 376     219,055     (140,806) $ 200 (1,210) (8,510) 78
Increase (Decrease) in Stockholders' Equity                              
Accounting Standards Update [Extensible List] Accounting Standards Update 2016-13 [Member]                            
Net loss attributable to common stockholders $ (17,307)             (11,632)     (5,675)        
Net income (loss) attributable to noncontrolling interest 35                           35
Shares issued in connection with Combination 1,347             1,347              
Foreign currency translation adjustment 583                       594   (11)
Issuance of restricted shares 0       $ 13     (13)              
Issuance of restricted shares (in shares)         1,247                    
Forfeiture of restricted shares 0       $ (2)     2              
Forfeiture of restricted shares (in shares)         (152)                    
Shares withheld pursuant to vesting of restricted stock (141)                         (141)  
Exercise of stock options (in shares)         16                    
Exercise of stock options 36             36              
Stock-based compensation 3,908             3,908              
Ending balance (in shares) at Dec. 31, 2023         38,716                    
Ending balance at Dec. 31, 2023 57,644       $ 387     212,703     (146,281)   (616) (8,651) 102
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to common stockholders (19,639)             (11,124)     (8,515)        
Net income (loss) attributable to noncontrolling interest 11                           11
Foreign currency translation adjustment (377)                       (369)   (8)
Forfeiture of restricted shares (in shares)         (7)                    
Shares withheld pursuant to vesting of restricted stock (31)                         (31)  
Stock-based compensation $ 1,028             1,028              
Ending balance (in shares) at Mar. 31, 2024 37,212       38,709                    
Ending balance at Mar. 31, 2024 $ 38,636       $ 387     202,607     (154,796)   (985) (8,682) 105
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to common stockholders (51,012)             (25)     (50,987)        
Net income (loss) attributable to noncontrolling interest 18                           18
Shares issued in connection with Combination   $ 362,005 $ 21,343     $ 707 $ 43   $ 361,298 $ 21,300          
Shares issued in connection with Combination (in shares)           70,704 4,286                
Foreign currency translation adjustment (7,843)       0     0         (7,865)   22
Proceeds from private placement, net of costs to issue common stock 66,459       $ 200     66,259              
Proceeds from private placement, net of costs to issue common stock (in shares)         20,000                    
Acquired through MiX Combination 7,823             7,818             5
Issuance of restricted shares 0       $ 1     (1)              
Issuance of restricted shares (in shares)         54                    
Shares withheld pursuant to vesting of restricted stock (2,836)                         (2,836)  
Exercise of stock options (in shares)         610                    
Exercise of stock options 1,898       $ 4     1,894              
Shares issued for transaction bonus 889       $ 1     888              
Shares issued for transaction bonus (in shares)         174                    
Issue of stock appreciation rights (in shares)         842                    
Stock-based compensation $ 9,362             9,362              
Ending balance (in shares) at Mar. 31, 2025 133,316       135,379                    
Ending balance at Mar. 31, 2025 $ 446,742       $ 1,343     $ 671,400     $ (205,783)   $ (8,850) $ (11,518) $ 150